Actively Recruiting
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
Led by Mayo Clinic · Updated on 2025-05-09
10500
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate and compare the effectiveness of active screening for SHD in asymptomatic outpatients referred for an ECG, using a combination of AI-ECG and FOCUS. Invites will be sent and participants enrolled electronically.
CONDITIONS
Official Title
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients over 18 years of age
- Echocardiogram is not clinically indicated
You will not qualify if you...
- Prior history of congenital or acquired structural heart disease including aortic stenosis, heart failure, left ventricular dysfunction, cardiac amyloidosis, hypertrophic cardiomyopathy, rheumatic heart disease, or congenital heart disease
- Echocardiogram performed within the last 12 months
- Scheduled for a clinically indicated future echocardiogram
- Unable to provide informed consent to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Catalina Paraschiv, M.D., Ph.D.
CONTACT
G
Gal Tsaban, M.D., Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here